The PACIRA Trial is a multi-center, randomized, study to evaluate the safety, efficacy and pharmacokinetics of a single injection femoral nerve block with liposome bupivacaine for postoperative pain for patients undergoing a total knee replacement.
The Clinical Trails Program at Northern Westchester Hospital is actively recruiting for this trial. Enrollment will end in October.
More Articles on Clinical Trials:
MUMC Participates in Trial of Facet Joint Replacement as Spinal Stenosis Treatment
Medtronic to Recruit 323 Patients for Back Pain Treatment Clinical Trial
FDA Approves Ampion Biologic Clinical Trial
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
